As long as they keep delivering like this on the actual science, they will win in the end. Interim SP means nothing really. This should help with the Torreya process I would have thought! Just need a ROW partner willing to fund P2 & P3 for NNZ-2591. I can't see how Acadia wouldn't want to be all over this. Fits their growth strategy perfectly. With the money they have backing them, just buy NEU outright!
Ann: Compelling results for 2591 dose ranging study in PMS model, page-7
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.000(0.00%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2 | $20.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.87 | 342 | 2 |
View Market Depth
| Last trade - 09.58am 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable